Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium
Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium is a paper indexed in PICO Portal from OpenAlex.
How many citations does Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium have?
Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium has 8 citations in the OpenAlex counts PICO Portal stores.
When was Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium published?
Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium has 2021 year in the PICO Portal index.
What is the open-access status of Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium?
Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium has closed oa status in the PICO Portal index.
What is the DOI of Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium?
The DOI for Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium is on the source record.
What is the PMID of Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium?
The PMID for Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium is on the source record.
What is the OpenAlex record for Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium?
The OpenAlex for Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium is on the source record.